Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Programmed death-ligand 1 mRNA 3' untranslated region (CD274 mRNA 3'UTR) is a critical regulatory segment of the CD274 transcript that governs the stability and translation of the PD-L1 protein (Kataoka et al., Nature 2016). This region contains multiple binding sites for microRNAs (miRNAs), such as miR-513 and miR-200, and RNA-binding proteins (RBPs) like AUF1 and HuR, which normally suppress PD-L1 expression to maintain immune homeostasis (Wang et al., Gene 2017). In various cancers, including T-cell lymphomas and gastric cancer, the 3'UTR of CD274 is frequently truncated or mutated, leading to the loss of these inhibitory regulatory elements and subsequent massive overexpression of PD-L1, which facilitates immune evasion by the tumor (Kataoka et al., Nature 2016). Consequently, the CD274 mRNA 3'UTR has emerged as a novel therapeutic target for RNA-based interventions, including antisense oligonucleotides (ASOs) and small molecules designed to restore regulatory control or induce mRNA degradation (Coelho et al., Trends in Cancer 2017). Targeting this region offers a potential strategy to modulate the PD-1/PD-L1 axis at the post-transcriptional level, potentially overcoming resistance to traditional monoclonal antibody therapies (Mezzadra et al., Nature 2017).
Modulation of mRNA stability and translation through recruitment of RNase H or steric hindrance of regulatory protein/miRNA binding to the 3' untranslated region.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Programmed death-ligand 1 mRNA 3' untranslated region (CD274 mRNA 3'UTR) (CD274 mRNA 3'UTR).